Advertisement

Sepsis pp 56-62 | Cite as

Severe Infections in the Returning Traveler

  • Jacob P. Wembri
  • Matthias L. Schmid
Chapter
  • 2k Downloads
Part of the Competency-Based Critical Care book series (CBCC)

The ease of air travel has made spread of infectious agents a global problem. There are a multitude of tropical diseases ranging from benign viral illnesses to highly contagious and life-threatening diseases and it is important to take a detailed clinical and travel history from the ill returning traveller, especially in the fi rst 4 weeks of return.

Keywords

Severe Acute Respiratory Syndrome Severe Malaria Cerebral Malaria Viral Hemorrhagic Fever Severe Acute Respiratory Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Suggested Reading

  1. British Infection Society. Algorithm for the initial assessment and management of malaria in adult (draft). 2004; www.britishinfectionsociety.org.Google Scholar
  2. Crowcroft N, Brown D, Gopal R, Morgan D. Current management of patients with viral haemorrhagic fevers in the United Kingdom. Eurosurveillance 2002;7(3):44–48.PubMedGoogle Scholar
  3. Greenwood BM, Bojang K, Whitty CJM, Targett GAT. Malaria. Lancet 2005;365:1487–1498.PubMedCrossRefGoogle Scholar
  4. Health Protection Agency. Interim guidelines for action in the event of a deliberate release: Viral Haemorrhagic fevers. HPA-Colindale 2003, Version 2.1. www.hpa.org.uk/infections/topics_az/deliberate_ release.Google Scholar
  5. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Eng J Med 2003;348: 1953–1966.CrossRefGoogle Scholar
  6. Lim WS, Anderson SR, Read RC. Hospital management of adults with severe acute respiratory (SARS) if SARS re-emerges-updated 10 February 2004. J Infect 2004;49:1–7.PubMedCrossRefGoogle Scholar
  7. Mahanty S, Bray M. Pathogenesis of fi loviral haemorrhagic fevers. Lancet Infect Dis 2004;4:487– 498.PubMedCrossRefGoogle Scholar
  8. McIntosh HM, Olliaro P. Artemisinin derivatives for treating severe malaria. The Cochrane database of systemic reviews 2000;2:CD000527.Google Scholar
  9. Peiris JSM, Chu CM, Cheng VCC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003;361:1767– 1772.PubMedCrossRefGoogle Scholar
  10. Richmond JK, Baglole DJ. Lassa fever: epidemiology, clinical features, and social consequences. Br Med J 2003;327:1271–1275.CrossRefGoogle Scholar
  11. So LKY, Lau ACW, Yam LYC, et al. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet 2003;361: 1615–1616.PubMedCrossRefGoogle Scholar
  12. Solomon T. Viral haemorrhagic fevers. In: Cook GC, Zumla A, eds. Manson's Tropical Diseases. London, Saunders 21st ed, 2003.Google Scholar
  13. South East Asia Quinine Artesunate Malaria Trial (SEAQUAMAT) group. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 2005;366:717–725.CrossRefGoogle Scholar
  14. World Health Organisation. Severe and complicated malaria. Transaction of the Royal Society of Tropical Medicine and Hygiene 2000;94(Suppl 1):S1–S90.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2008

Authors and Affiliations

  • Jacob P. Wembri
    • 1
  • Matthias L. Schmid
    • 2
  1. 1.Department of Infection and Tropical MedicineNewcastle General Hospital Newcastle-upon-TyneUK
  2. 2.Consultant Physician and Clinical Senior Lecturer Department of Infection and Tropical MedicineNewcastle General Hospital Newcastle-upon-TyneUK

Personalised recommendations